A detailed history of Brandywine Global Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 1,212,236 shares of BMY stock, worth $70.3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,212,236
Previous 1,229,749 1.42%
Holding current value
$70.3 Million
Previous $51.1 Million 22.83%
% of portfolio
0.44%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $694,565 - $906,297
-17,513 Reduced 1.42%
1,212,236 $62.7 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $3.73 Million - $4.92 Million
-92,768 Reduced 7.01%
1,229,749 $51.1 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $5.09 Million - $5.77 Million
-106,108 Reduced 7.43%
1,322,517 $71.7 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $4.34 Million - $5.18 Million
89,508 Added 6.68%
1,428,625 $73.3 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $53.9 Million - $60.3 Million
-931,401 Reduced 41.02%
1,339,117 $77.7 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $10.7 Million - $11.8 Million
-167,376 Reduced 6.87%
2,270,518 $145 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $7.7 Million - $8.73 Million
117,125 Added 5.05%
2,437,894 $169 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $16.4 Million - $19.4 Million
239,130 Added 11.49%
2,320,769 $167 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $22,204 - $13.1 Million
-170,805 Reduced 7.58%
2,081,639 $148 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $30.4 Million - $33.5 Million
418,875 Added 22.84%
2,252,444 $173 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $45.5 Million - $54.6 Million
740,694 Added 67.77%
1,833,569 $134 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $21.1 Million - $24.6 Million
394,090 Added 56.4%
1,092,875 $68.1 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $6.93 Million - $8.12 Million
117,132 Added 20.14%
698,785 $41.3 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $475,221 - $517,515
7,676 Added 1.34%
581,653 $38.9 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $10.6 Million - $12 Million
179,226 Added 45.4%
573,977 $36.2 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $6.44 Million - $7.3 Million
-111,571 Reduced 22.04%
394,751 $24.5 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $414,989 - $459,862
7,226 Added 1.45%
506,322 $30.5 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $725,213 - $847,846
-13,229 Reduced 2.58%
499,096 $29.3 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $20 Million - $29.1 Million
-431,255 Reduced 45.7%
512,325 $28.6 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $48.5 Million - $63.3 Million
-985,937 Reduced 51.1%
943,580 $59.8 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $4.9 Million - $5.81 Million
-114,485 Reduced 5.6%
1,929,517 $97.8 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $7.35 Million - $8.12 Million
164,650 Added 8.76%
2,044,002 $92.7 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $3.85 Million - $4.59 Million
85,282 Added 4.75%
1,879,352 $89.7 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $31.5 Million - $40.8 Million
645,716 Added 56.23%
1,794,070 $93.3 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $2.03 Million - $2.29 Million
-36,732 Reduced 3.1%
1,148,354 $71.3 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $59.9 Million - $74.6 Million
1,185,086 New
1,185,086 $65.6 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $64.6 Million - $74.4 Million
-1,078,661 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $51.4 Million - $56 Million
857,411 Added 387.53%
1,078,661 $66.1 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $418,091 - $482,511
-7,570 Reduced 3.31%
221,250 $14.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
228,820
228,820 $12.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.